X053X4B
Destruction Brain to New Technology Group 11 with Focused Ultrasound Therapy, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 0 Nervous System |
| Operation | 5 Destruction |
| Body Part | 3 Brain |
| Approach | X External |
| Device | 4 Focused Ultrasound Therapy |
| Qualifier | B New Technology Group 11 |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers newer, technologically distinct methods of destroying targeted nervous system tissue, typically portions of brain tissue, using energy-based approaches that differ meaningfully from older destruction techniques already captured elsewhere in ICD-10-PCS. These procedures are most often used to treat conditions such as movement disorders, certain seizure foci, or other neurological conditions where a small, precisely targeted area of tissue is eradicated to relieve symptoms, without physically removing that tissue from the body.
Because these procedures rely on emerging technology, such as image-guided thermal or focused energy systems, they are tracked separately from standard destruction codes so that hospitals and payers can monitor the use, cost, and outcomes of new devices before they become standard practice. Patients typically undergo these procedures in a specialized neurology or neurosurgery setting, often guided by real-time imaging to confirm the treatment is limited to the intended target and spares surrounding healthy tissue.
Anatomy & Axis Detail
Brain
In this context, destruction of brain tissue refers to targeted ablation of a specific, small volume of neural tissue - such as the thalamus or a discrete motor circuit - performed to treat conditions like essential tremor or medication-refractory Parkinsonian tremor. The procedure is typically carried out using incisionless, image-guided energy delivery such as MR-guided focused ultrasound, which allows the surgeon to heat and destroy a precise focal target while continuously monitoring the effect in real time and adjusting before the lesion is finalized. Because the brain is functionally organized with critical structures in close proximity, the approach relies heavily on stereotactic imaging guidance rather than open exposure, and documentation should identify the specific target nucleus and confirm that the new-technology energy modality, rather than a conventional surgical lesion, was used.
Approach: External
External approach in New Technology applies to procedures performed directly on the skin, mucous membranes, or via direct visualization without penetrating a body cavity, such as applying or activating a device against the body surface. It contrasts with Percutaneous approaches, which require instrument entry through the skin rather than surface-level contact.
Device / Substance / Technology: Focused Ultrasound Therapy
Focused Ultrasound Therapy describes a device-based technique that concentrates ultrasound waves at a precise focal point to produce a therapeutic effect, such as thermal or mechanical tissue modulation, without necessarily destroying tissue outright. It is used for select new-technology therapeutic applications. It differs from Ultrasound Ablation, which specifically denotes destructive ablative intent rather than modulatory therapy.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Assigning a code from this family requires documentation identifying the specific new technology or device used to destroy the tissue, since New Technology section codes are tied to a particular approved technology rather than a general technique. The operative note should describe the target location within the nervous system, confirm that tissue was destroyed in place rather than excised, and reference the specific energy modality or system involved. A frequent error is defaulting to a standard Medical and Surgical section destruction code when the technology actually qualifies for a New Technology code, or vice versa, applying a New Technology code when the device used does not match the approved technology tied to that code.
Commonly Confused With
This family is easily confused with standard Destruction codes in the Medical and Surgical section's Central Nervous System body system, which cover the same root operation concept but use conventional, previously established techniques. It can also be confused with Excision or Resection, which involve physically removing tissue rather than eradicating it in place, and with Ablation-type procedures documented under different terminology; coders should verify whether tissue was removed from the body or destroyed without removal before assigning either root operation.